NEW YORK, July 30, 2026, 2:01 p.m. EDT — Shares of UiPath NYSE:PATH declined after the company forecasted slower additions to annualized recurring revenue for the second quarter.
- The stock dropped 3.3% to $12.18 in early U.S. trading.
- Initial estimates indicate Q2 guidance suggests net new ARR between $28 million and $33 million.
- Initial estimate: market value, adjusted for cash, is approximately 2.8 times the projected revenue for fiscal 2027.
UiPath shares declined even as U.S. equities rose on Thursday. The company’s investor updates have not posted anything fresh since June 16, making the second quarter outlook the main reference point for investors.
Annualized renewal run-rate, or ARR, is the main metric. UiPath forecasts $1.929 billion to $1.934 billion for July 31, up from $1.901 billion on April 30.
Initial estimate: the guidance suggests net new ARR between $28 million and $33 million. This midpoint is 38% lower than the $49 million posted in Q1. Compared to $31 million in the same period last year, it shows little change. Seasonal trends impact quarter-to-quarter performance. The lack of year-over-year growth remains significant.
The operating cadence is detailed below. Figures marked with an asterisk are preliminary estimates.
| Metric | Q2 FY2026 actual | Q1 FY2027 actual | Q2 FY2027 guide |
|---|---|---|---|
| Revenue | $362m | $418m | $395m–$400m |
| Year-on-year revenue growth | 14% | 17% | 9.1%–10.5% |
| Ending ARR | $1.723bn | $1.901bn | $1.929bn–$1.934bn |
| Net new ARR | $31m | $49m | $28m–$33m |
| Dollar-based net retention | 108% | 109% | Not provided |
| Non-GAAP operating income | $62m | $92m | Roughly $75m |
Company guidance provides preliminary estimates for Q2 FY2027 growth and net new ARR.
Chief Executive Daniel Dines stated in May that agentic offerings were “moving from pilot to production.” The Q2 ARR bridge will indicate how rapidly this transition reflects in contractual agreements. UiPath, Inc.
Early estimates show Q2 revenue growth easing to a range of 9.1%–10.5%. The projected non-GAAP operating margin is roughly 18.9% at the midpoint, exceeding last year’s 17.1% but lower than the 22.0% reported in Q1.
Thursday’s software market activity was selective rather than widely positive.
| Company | Latest price | Day move | Intraday range |
|---|---|---|---|
| UiPath Inc. NYSE:PATH | $12.18 | down 3.3% | $11.67–$12.63 |
| Microsoft Corp. NASDAQ:MSFT | $456.31 | up 16.8% | $417.00–$457.90 |
| Salesforce Inc. NYSE:CRM | $180.45 | down 4.2% | $175.95–$189.17 |
| ServiceNow Inc. NYSE:NOW | $109.31 | down 5.6% | $106.45–$116.72 |
Most recent trades as of 1:46 p.m. EDT. Day changes are initial estimates based on current prices and previous closing values.
Microsoft shares rose following an outlook for higher sales and cloud expansion. The company’s capital spending projection came in beneath expectations. In contrast, Salesforce, ServiceNow, and UiPath declined. The divergence indicates investors favored proven AI gains instead of general software involvement.
Seth Hickle explained the benchmark. “This earnings season is about AI execution, not AI enthusiasm,” said the Mindset Wealth Management investment chief. Reuters
UiPath increased its full-year guidance following Q1. The midpoint of its profit outlook saw the bigger adjustment.
| Fiscal 2027 metric | March outlook | May outlook | Midpoint change |
|---|---|---|---|
| Revenue | $1.754bn–$1.759bn | $1.776bn–$1.781bn | +$22m |
| Ending ARR | $2.051bn–$2.056bn | $2.058bn–$2.063bn | +$7m |
| Non-GAAP operating income | Approximately $415m | Approximately $430m | +$15m |
These midpoint adjustments are early estimates.
The upgrade suggests there is no widespread decline in demand. However, it still leaves the immediate outlook for bookings uncertain. Guidance for ARR at the midpoint edged up by just around 0.3%. The projected operating income was raised by approximately 3.6%.
The valuation demonstrates that tension.
| Valuation summary | Value |
|---|---|
| Present market cap | $6.43bn |
| Cash and liquid investments | $1.42bn |
| Market value net of cash | $5.01bn |
| FY2027 projected revenue midpoint | $1.779bn |
| Net market value/revenue | 2.8 times |
| FY2027 ending ARR estimate midpoint | $2.061bn |
| Net market value/ending ARR* | 2.4 times |
Early estimates. Cash reflects figures from April 30; market capitalization is based on the most recent price data.
Preliminary figures show that cash is approximately 22% of market capitalization. This lessens balance-sheet risk but does not lead to sustained growth.
UiPath allocated $243.8 million for share buybacks in Q1, at an average price of $11.47 per share. The company acquired an additional 2.4 million shares at $9.63 each by May 15. On Thursday, the stock traded above both these prices.
Risks: ARR might fall short of the projected range. Growth could soften due to pricing competition, challenges with customer retention, or broader macroeconomic disruptions. Stock-based compensation could offset advantages gained from share repurchases.
The ARR balance on July 31 offers the clearest read. At nearly $12, UiPath trades at 2.8 times cash-adjusted revenue. Accelerating ARR growth remains the crucial element.
